Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions
Tel Aviv and Boston--(BUSINESS WIRE)--Dec 18, 2025-- Syremis Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health, today announced its launch with a $165 million …